| Year |
Citation |
Score |
| 2024 |
Jessa S, De Cola A, Chandarana B, McNicholas M, Hébert S, Ptack A, Faury D, Tsai JW, Korshunov A, Phoenix TN, Ellezam B, Jones DTW, Taylor MD, Bandopadhayay P, Pathania M, et al. FOXR2 targets LHX6+/DLX+ neural lineages to drive CNS neuroblastoma. Cancer Research. PMID 39495206 DOI: 10.1158/0008-5472.CAN-24-2248 |
0.729 |
|
| 2024 |
Forrest SJ, Gupta H, Ward A, Li YY, Doan D, Al-Ibraheemi A, Alexandrescu S, Bandopadhayay P, Shusterman S, Mullen EA, Collins NB, Chi SN, Wright KD, Kumari P, Mazor T, et al. Author Correction: Molecular profiling of 888 pediatric tumors informs future precision trials and data-sharing initiatives in pediatric cancer. Nature Communications. 15: 7218. PMID 39174503 DOI: 10.1038/s41467-024-51184-1 |
0.469 |
|
| 2024 |
Tsiami F, Lago C, Pozza N, Piccioni F, Zhao X, Lülsberg F, Root DE, Tiberi L, Kool M, Schittenhelm J, Bandopadhayay P, Segal RA, Tabatabai G, Merk DJ. Genome-wide CRISPR-Cas9 knockout screens identify DNMT1 as a druggable dependency in sonic hedgehog medulloblastoma. Acta Neuropathologica Communications. 12: 125. PMID 39107797 DOI: 10.1186/s40478-024-01831-x |
0.306 |
|
| 2024 |
Forrest SJ, Gupta H, Ward A, Li YY, Doan D, Al-Ibraheemi A, Alexandrescu S, Bandopadhayay P, Shusterman S, Mullen EA, Collins NB, Chi SN, Wright KD, Kumari P, Mazor T, et al. Molecular profiling of 888 pediatric tumors informs future precision trials and data-sharing initiatives in pediatric cancer. Nature Communications. 15: 5837. PMID 38992034 DOI: 10.1038/s41467-024-49944-0 |
0.504 |
|
| 2024 |
Giacomini G, Piquet S, Chevallier O, Dabin J, Bai SK, Kim B, Siddaway R, Raught B, Coyaud E, Shan CM, Reid RJD, Toda T, Rothstein R, Barra V, Wilhelm T, ... ... Bandopadhayay P, et al. Aberrant DNA repair reveals a vulnerability in histone H3.3-mutant brain tumors. Nucleic Acids Research. PMID 38214234 DOI: 10.1093/nar/gkad1257 |
0.737 |
|
| 2023 |
Hofman DA, Ruiz-Orera J, Yannuzzi I, Murugesan R, Brown A, Clauser KR, Condurat AL, van Dinter JT, Engels SAG, Goodale A, van der Lugt J, Abid T, Wang L, Zhou KN, Vogelzang J, ... ... Bandopadhayay P, et al. Translation of non-canonical open reading frames as a cancer cell survival mechanism in childhood medulloblastoma. Molecular Cell. PMID 38176414 DOI: 10.1016/j.molcel.2023.12.003 |
0.683 |
|
| 2023 |
Koschmann C, Al-Holou WN, Alonso MM, Anastas J, Bandopadhayay P, Barron T, Becher O, Cartaxo R, Castro MG, Chung C, Clausen M, Dang D, Doherty R, Duchatel R, Dun M, et al. A road map for the treatment of pediatric diffuse midline glioma. Cancer Cell. PMID 38039965 DOI: 10.1016/j.ccell.2023.11.002 |
0.76 |
|
| 2023 |
Hofman DA, Ruiz-Orera J, Yannuzzi I, Murugesan R, Brown A, Clauser KR, Condurat AL, van Dinter JT, Engels SAG, Goodale A, van der Lugt J, Abid T, Wang L, Zhou KN, Vogelzang J, ... ... Bandopadhayay P, et al. Translation of non-canonical open reading frames as a cancer cell survival mechanism in childhood medulloblastoma. Biorxiv : the Preprint Server For Biology. PMID 37205492 DOI: 10.1101/2023.05.04.539399 |
0.69 |
|
| 2023 |
Blandin AF, Giglio R, Graham MS, Garcia G, Malinowski S, Woods JK, Ramkissoon S, Ramkissoon L, Dubois F, Schoolcraft K, Tsai J, Wang D, Jones R, Vogelzang J, Pelton K, ... ... Bandopadhayay P, et al. ALK amplification and rearrangements are recurrent targetable events in congenital and adult glioblastoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 36780194 DOI: 10.1158/1078-0432.CCR-21-3521 |
0.778 |
|
| 2023 |
Rheinbay E, Nielsen MM, Abascal F, Wala JA, Shapira O, Tiao G, Hornshøj H, Hess JM, Juul RI, Lin Z, Feuerbach L, Sabarinathan R, Madsen T, Kim J, Mularoni L, ... ... Bandopadhayay P, et al. Author Correction: Analyses of non-coding somatic drivers in 2,658 cancer whole genomes. Nature. PMID 36697832 DOI: 10.1038/s41586-022-05599-9 |
0.718 |
|
| 2022 |
Tsai JW, Choi JJ, Ouaalam H, Murillo EA, Yeo KK, Vogelzang J, Sousa C, Woods JK, Ligon KL, Warfield SK, Bandopadhayay P, Cooney TM. Integrated response analysis of pediatric low-grade gliomas during and after targeted therapy treatment. Neuro-Oncology Advances. 5: vdac182. PMID 36926246 DOI: 10.1093/noajnl/vdac182 |
0.728 |
|
| 2022 |
Selt F, Sigaud R, Valinciute G, Sievers P, Zaman J, Alco C, Schmid S, Peterziel H, Tsai JW, Guiho R, Martínez-Barbera JP, Pusch S, Deng J, Zhai Y, van Tilburg CM, ... ... Bandopadhayay P, et al. BH3 mimetics targeting BCL-XL impact the senescent compartment of pilocytic astrocytoma. Neuro-Oncology. PMID 35977048 DOI: 10.1093/neuonc/noac199 |
0.71 |
|
| 2022 |
Coy S, Wang S, Stopka SA, Lin JR, Yapp C, Ritch CC, Salhi L, Baker GJ, Rashid R, Baquer G, Regan M, Khadka P, Cole KA, Hwang J, Wen PY, ... Bandopadhayay P, et al. Single cell spatial analysis reveals the topology of immunomodulatory purinergic signaling in glioblastoma. Nature Communications. 13: 4814. PMID 35973991 DOI: 10.1038/s41467-022-32430-w |
0.789 |
|
| 2022 |
Tsai JW, Cejas P, Wang DK, Patel S, Wu DW, Arounleut P, Wei X, Zhou N, Syamala S, Dubois FPB, Crane A, Pelton K, Vogelzang J, Sousa C, Baguette A, ... ... Bandopadhayay P, et al. FOXR2 is an epigenetically regulated pan-cancer oncogene that activates ETS transcriptional circuits. Cancer Research. PMID 35802025 DOI: 10.1158/0008-5472.CAN-22-0671 |
0.801 |
|
| 2022 |
Dubois FPB, Shapira O, Greenwald NF, Zack T, Wala J, Tsai JW, Crane A, Baguette A, Hadjadj D, Harutyunyan AS, Kumar KH, Blattner-Johnson M, Vogelzang J, Sousa C, Kang KS, ... ... Bandopadhayay P, et al. Structural variants shape driver combinations and outcomes in pediatric high-grade glioma. Nature Cancer. PMID 35788723 DOI: 10.1038/s43018-022-00403-z |
0.78 |
|
| 2022 |
Khadka P, Reitman ZJ, Lu S, Buchan G, Gionet G, Dubois F, Carvalho DM, Shih J, Zhang S, Greenwald NF, Zack T, Shapira O, Pelton K, Hartley R, Bear H, ... ... Bandopadhayay P, et al. PPM1D mutations are oncogenic drivers of de novo diffuse midline glioma formation. Nature Communications. 13: 604. PMID 35105861 DOI: 10.1038/s41467-022-28198-8 |
0.789 |
|
| 2022 |
Pagès M, Rotem D, Gydush G, Reed S, Rhoades J, Ha G, Lo C, Fleharty M, Duran M, Jones R, Becker S, Haller M, Sinai CE, Goumnerova L, Golub TR, ... ... Bandopadhayay P, et al. Liquid biopsy detection of genomic alterations in pediatric brain tumors from cell-free DNA in peripheral blood, CSF, and urine. Neuro-Oncology. PMID 34984433 DOI: 10.1093/neuonc/noab299 |
0.513 |
|
| 2021 |
Dharia NV, Kugener G, Guenther LM, Malone CF, Durbin AD, Hong AL, Howard TP, Bandopadhayay P, Wechsler CS, Fung I, Warren AC, Dempster JM, Krill-Burger JM, Paolella BR, Moh P, et al. A first-generation pediatric cancer dependency map. Nature Genetics. PMID 33753930 DOI: 10.1038/s41588-021-00819-w |
0.718 |
|
| 2021 |
Tsai JW, Manoharan N, Alexandrescu S, Zimmerman MA, Scully J, Chordas C, Clymer J, Wright KD, Filbin M, Ullrich NJ, Marcus KJ, Haas-Kogan D, Chi SN, Bandopadhayay P, Yeo KK. Outcomes after first relapse of childhood intracranial ependymoma. Pediatric Blood & Cancer. e28930. PMID 33565268 DOI: 10.1002/pbc.28930 |
0.68 |
|
| 2021 |
Rendo V, Lupien L, Khuu N, Pelton K, Lu S, Khadka P, Langhnoja J, Phoenix T, Ligon K, Bandopadhayay P, Beroukhim R. OMRT-6. Optimizing MDM2 inhibition for the treatment of high-grade glioma Neuro-Oncology Advances. 3: ii8-ii8. DOI: 10.1093/noajnl/vdab070.031 |
0.331 |
|
| 2021 |
Tsiami F, Piccioni F, Root D, Bandopadhayay P, Segal R, Tabatabai G, Merk D. EXTH-71. FUNCTIONAL GENOMICS IDENTIFIES EPIGENETIC REGULATORS AS NOVEL THERAPEUTIC TARGETS FOR SONIC HEDGEHOG MEDULLOBLASTOMA Neuro-Oncology. 23: vi179-vi179. DOI: 10.1093/neuonc/noab196.710 |
0.356 |
|
| 2021 |
Rendo V, Lupien L, Khuu N, Pelton K, Elcavage L, Lu S, Khadka P, Langhnoja J, Phoenix T, Ligon K, Bandopadhayay P, Beroukhim R. DDRE-14. OPTIMIZING MDM2 INHIBITION FOR THE TREATMENT OF HIGH-GRADE GLIOMA Neuro-Oncology. 23: vi77-vi77. DOI: 10.1093/neuonc/noab196.298 |
0.372 |
|
| 2020 |
Chen CCL, Deshmukh S, Jessa S, Hadjadj D, Lisi V, Andrade AF, Faury D, Jawhar W, Dali R, Suzuki H, Pathania M, A D, Dubois F, Woodward E, Hébert S, ... ... Bandopadhayay P, et al. Histone H3.3G34-Mutant Interneuron Progenitors Co-opt PDGFRA for Gliomagenesis. Cell. PMID 33259802 DOI: 10.1016/j.cell.2020.11.012 |
0.74 |
|
| 2020 |
Feldman D, Tsai F, Garrity AJ, O'Rourke R, Brenan L, Ho P, Gonzalez E, Konermann S, Johannessen CM, Beroukhim R, Bandopadhayay P, Blainey PC. CloneSifter: enrichment of rare clones from heterogeneous cell populations. Bmc Biology. 18: 177. PMID 33234154 DOI: 10.1186/s12915-020-00911-3 |
0.475 |
|
| 2020 |
Touat M, Li YY, Boynton AN, Spurr LF, Iorgulescu JB, Bohrson CL, Cortes-Ciriano I, Birzu C, Geduldig JE, Pelton K, Lim-Fat MJ, Pal S, Ferrer-Luna R, Ramkissoon SH, Dubois F, ... ... Bandopadhayay P, et al. Mechanisms and therapeutic implications of hypermutation in gliomas. Nature. 580: 517-523. PMID 32322066 DOI: 10.1038/S41586-020-2209-9 |
0.792 |
|
| 2020 |
Rheinbay E, Nielsen MM, Abascal F, Wala JA, Shapira O, Tiao G, Hornshøj H, Hess JM, Juul RI, Lin Z, Feuerbach L, Sabarinathan R, Madsen T, Kim J, Mularoni L, ... ... Bandopadhayay P, et al. Analyses of non-coding somatic drivers in 2,658 cancer whole genomes. Nature. 578: 102-111. PMID 32025015 DOI: 10.1038/s41586-020-1965-x |
0.746 |
|
| 2020 |
Kurppa KJ, Liu Y, To C, Zhang T, Fan M, Vajdi A, Knelson EH, Xie Y, Lim K, Cejas P, Portell A, Lizotte PH, Ficarro SB, Li S, Chen T, ... ... Bandopadhayay P, et al. Treatment-Induced Tumor Dormancy through YAP-Mediated Transcriptional Reprogramming of the Apoptotic Pathway. Cancer Cell. 37: 104-122.e12. PMID 31935369 DOI: 10.1016/J.Ccell.2019.12.006 |
0.509 |
|
| 2020 |
Touat M, Li YY, Boynton AN, Spurr LF, Iorgulescu B, Bohrson CL, Cortes-Ciriano I, Geduldig JE, Pelton K, Lim-Fat MJ, Pal S, Ramkissoon SH, Dubois F, Bellamy C, Currimjee N, ... ... Bandopadhayay P, et al. Abstract 5705: Mechanisms and therapeutic implications of hypermutation in gliomas Cancer Research. 80: 5705-5705. DOI: 10.1158/1538-7445.Am2020-5705 |
0.685 |
|
| 2020 |
Condurat A, Wefers A, Gonzalez E, Doshi J, Khadka P, Jessa S, Tsai J, Buchan G, Rouleau C, Abid T, Goodale A, Persky N, Beroukhim R, Root D, Ligon K, ... ... Bandopadhayay P, et al. LGG-35. FUNCTIONAL GENOMIC APPROACHES TO IDENTIFY THERAPEUTIC TARGETS IN MYB AND MYBL1 EXPRESSING PEDIATRIC LOW-GRADE GLIOMAS Neuro-Oncology. 22: iii373-iii373. DOI: 10.1093/neuonc/noaa222.417 |
0.76 |
|
| 2020 |
Dubois F, Shapira O, Greenwald N, Zack T, Tsai JW, Harutyunyan AS, Kumar K, Sinai C, Malkin H, Jones R, Ho P, O’Rourke R, Kang KS, Jabado N, Kieran MW, ... ... Bandopadhayay P, et al. HGG-41. STRUCTURAL VARIANT DRIVERS IN PEDIATRIC HIGH-GRADE GLIOMA Neuro-Oncology. 22: iii351-iii351. DOI: 10.1093/neuonc/noaa222.322 |
0.732 |
|
| 2020 |
Boynton A, Pal S, Touat M, Currimjee N, Qian K, Bellamy C, Ho P, Berstler J, Ligon K, Beroukhim R, Bandopadhayay P. HGG-32. UNCOVERING THERAPEUTIC VULNERABILITIES IN MISMATCH REPAIR-DEFICIENT GLIOMAS Neuro-Oncology. 22: iii349-iii349. DOI: 10.1093/neuonc/noaa222.314 |
0.317 |
|
| 2020 |
Khadka P, Reitman Z, Lu S, Buchan G, Hartley R, Bear H, Georgis Y, Jarmale S, Schoolcraft K, Miller P, Gonzalez E, Gionet G, Qian K, Melanson R, Keshishian H, ... ... Bandopadhayay P, et al. DIPG-53. CHARACTERIZING THE ROLE OF PPM1D MUTATIONS IN THE PATHOGENESIS OF DIFFUSE INTRINSIC PONTINE GLIOMAS (DIPGS) Neuro-Oncology. 22: iii297-iii297. DOI: 10.1093/neuonc/noaa222.098 |
0.328 |
|
| 2020 |
Tsai JW, Patel SK, Bear H, Dubois F, Khadka P, Lu S, Gonzalez E, Ligon K, Bandopadhayay P, Phoenix TN. DIPG-22. DISSECTING THE ONCOGENIC ROLE OF FOXR2 IN DIFFUSE INTRINSIC PONTINE GLIOMA Neuro-Oncology. 22: iii291-iii291. DOI: 10.1093/neuonc/noaa222.072 |
0.752 |
|
| 2019 |
Barthel FP, Johnson KC, Varn FS, Moskalik AD, Tanner G, Kocakavuk E, Anderson KJ, Abiola O, Aldape K, Alfaro KD, Alpar D, Amin SB, Ashley DM, Bandopadhayay P, Barnholtz-Sloan JS, et al. Longitudinal molecular trajectories of diffuse glioma in adults. Nature. PMID 31748746 DOI: 10.1038/S41586-019-1775-1 |
0.532 |
|
| 2019 |
Reitman ZJ, Paolella BR, Bergthold G, Pelton K, Becker S, Jones R, Sinai CE, Malkin H, Huang Y, Grimmet L, Herbert ZT, Sun Y, Weatherbee JL, Alberta JA, Daley JF, ... ... Bandopadhayay P, et al. Mitogenic and progenitor gene programmes in single pilocytic astrocytoma cells. Nature Communications. 10: 3731. PMID 31427603 DOI: 10.1038/S41467-019-11493-2 |
0.791 |
|
| 2019 |
Bandopadhayay P, Piccioni F, O'Rourke R, Ho P, Gonzalez EM, Buchan G, Qian K, Gionet G, Girard E, Coxon M, Rees MG, Brenan L, Dubois F, Shapira O, Greenwald NF, et al. Neuronal differentiation and cell-cycle programs mediate response to BET-bromodomain inhibition in MYC-driven medulloblastoma. Nature Communications. 10: 2400. PMID 31160565 DOI: 10.1038/S41467-019-10307-9 |
0.776 |
|
| 2019 |
Hong AL, Tseng YY, Wala JA, Kim WJ, Kynnap BD, Doshi MB, Kugener G, Sandoval GJ, Howard TP, Li J, Yang X, Tillgren M, Ghandi M, Sayeed A, Deasy R, ... ... Bandopadhayay P, et al. Renal medullary carcinomas depend upon loss and are sensitive to proteasome inhibition. Elife. 8. PMID 30860482 DOI: 10.7554/Elife.44161 |
0.725 |
|
| 2019 |
Miklja Z, Pasternak A, Stallard S, Nicolaides T, Kline-Nunnally C, Cole B, Beroukhim R, Bandopadhayay P, Chi S, Ramkissoon SH, Mullan B, Bruzek AK, Gauthier A, Garcia T, Atchison C, et al. Molecular profiling and targeted therapy in pediatric gliomas: review and consensus recommendations. Neuro-Oncology. PMID 30805642 DOI: 10.1093/Neuonc/Noz022 |
0.506 |
|
| 2019 |
Hong AL, Tseng Y, Wala JA, Kim W, Kynnap BD, Doshi MB, Kugener G, Sandoval GJ, Howard TP, Li J, Yang X, Tillgren M, Ghandi M, Sayeed A, Deasy R, ... ... Bandopadhayay P, et al. Author response: Renal medullary carcinomas depend upon SMARCB1 loss and are sensitive to proteasome inhibition Elife. DOI: 10.7554/Elife.44161.051 |
0.674 |
|
| 2019 |
Reitman ZJ, Paolella B, Bergthold G, Pelton K, Jones R, Becker S, Sinai CE, Malkin H, Huang Y, Grimmett L, Herbert ZT, Sun Y, Weatherbee J, Alberta J, Daley J, ... ... Bandopadhayay P, et al. Abstract 3647: Single cell RNA sequencing reveals mitogenic and progenitor gene programs inBRAF-rearranged pilocytic astrocytomas Cancer Research. 79: 3647-3647. DOI: 10.1158/1538-7445.Am2019-3647 |
0.823 |
|
| 2019 |
Touat M, Li Y, Boynton A, Spurr L, Iorgulescu B, Birzu C, Pal S, Ferrer-Luna R, Geduldig J, Bellamy C, Younan N, Baldini C, Verreault M, Guillerm E, Ammari S, ... ... Bandopadhayay P, et al. DRES-08. CLINICAL SIGNIFICANCE OF HYPERMUTATION IN GLIOMAS Neuro-Oncology. 21: vi73-vi73. DOI: 10.1093/Neuonc/Noz175.296 |
0.656 |
|
| 2019 |
Touat M, Li Y, Boynton A, Spurr L, Iorglescu B, Geduldig J, Birzu C, Lim Fat M, Santagata S, Coulet F, Beuvon F, Mokhtari K, Giry M, Block S, Guillerm E, ... ... Bandopadhayay P, et al. OS9.1 Clinical significance of hypermutation in gliomas Neuro-Oncology. 21: iii18-iii18. DOI: 10.1093/Neuonc/Noz126.059 |
0.508 |
|
| 2019 |
Lam FC, Vu-Han T, Van de Kooj B, Kong YW, Bandopadhayay P, Beroukhim R, Sarkaria J, Hammond P, Yaffe M. THER-22. BROMODOMAIN INHIBITORS INDUCE DOWNREGULATION OF DNA DAMAGE REPAIR PATHWAYS AND OFFER NOVEL SYNERGISTIC COMBINATIONS WITH ENHANCED SAFETY PROFILES FOR THE TREATMENT OF MEDULLOBLASTOMA AND GLIOBLASTOMA Neuro-Oncology. 21: ii118-ii118. DOI: 10.1093/Neuonc/Noz036.227 |
0.415 |
|
| 2019 |
Bandopadhayay P, Piccioni F, O’Rourke R, Ho P, Gonzalez E, Gionet G, Qian K, Clymer J, Balboni-Iniguez A, Lam F, Shapira O, Greenwald N, Rashid R, Tiv H, Coy S, et al. MEDU-37. NEURONAL DIFFERENTIATION AND CELL-CYCLE PROGRAMS MEDIATE RESPONSE AND RESISTANCE TO BET-BROMODOMAIN INHIBITION IN MYC-DRIVEN MEDULLOBLASTOMA Neuro-Oncology. 21: ii111-ii111. DOI: 10.1093/Neuonc/Noz036.195 |
0.438 |
|
| 2019 |
Clymer J, Gionet G, Gonzalez E, Buchan G, Qian K, Ho P, O’Rourke R, Balboni-Iniguez A, Stegmaier K, Ligon K, Piccioni F, Johannessen C, Beroukhim R, Bandopadhayay P. Medu-36. Bcl2 Family Members Attenuate Response Of Myc-Driven Medulloblastomas To Bet-Bromodomain Inhibition Neuro-Oncology. 21. DOI: 10.1093/Neuonc/Noz036.194 |
0.394 |
|
| 2019 |
Reitman Z, Paolella B, Bergthold G, Pelton K, Becker S, Jones R, Sinai C, Malkin H, Huang Y, Grimmet L, Herbert Z, Sun Y, Weatherbee J, Qian K, Condurat A, ... ... Bandopadhayay P, et al. LGG-05. SINGLE CELL RNA SEQUENCING REVEALS MITOGENIC AND PROGENITOR GENE PROGRAMS IN BRAF-REARRANGED PILOCYTIC ASTROCYTOMAS Neuro-Oncology. 21: ii99-ii99. DOI: 10.1093/Neuonc/Noz036.148 |
0.778 |
|
| 2019 |
Khadka P, Reitman ZJ, Buchan G, Hartley R, Bear H, Georgis Y, Jarmale S, Schoolcraft K, Miller P, Stiles CD, Chowdhury D, Haas-Kogan D, Johannessen C, Ebert BL, Ligon KL, ... ... Bandopadhayay P, et al. DIPG-12. CHARACTERIZING THE ROLE OF PPM1D MUTATIONS IN THE PATHOGENESIS OF DIFFUSE INTRINSIC PONTINE GLIOMAS (DIPGs) Neuro-Oncology. 21: ii70-ii71. DOI: 10.1093/Neuonc/Noz036.033 |
0.456 |
|
| 2019 |
Poussaint TY, Vajapeyam S, Brown D, Kao P, Ma C, Greenspan L, Gupta N, Goumnerova L, Bandopadhayay P, Beroukhim R, Ligon K, Kieran M, Chi S, Wright K. Dipg-02. Translational Mr Imaging Correlates For Molecular Analyses In Diffuse Intrinsic Pontine Glioma (Dipg) Neuro-Oncology. 21. DOI: 10.1093/Neuonc/Noz036.023 |
0.416 |
|
| 2018 |
Bandopadhayay P, Meyerson M. Landscapes of childhood tumours. Nature. 555: 316-317. PMID 32094694 DOI: 10.1038/D41586-018-01648-4 |
0.425 |
|
| 2018 |
Iniguez AB, Alexe G, Wang EJ, Roti G, Patel S, Chen L, Kitara S, Conway A, Robichaud AL, Stolte B, Bandopadhayay P, Goodale A, Pantel S, Lee Y, Cheff DM, et al. Resistance to Epigenetic-Targeted Therapy Engenders Tumor Cell Vulnerabilities Associated with Enhancer Remodeling. Cancer Cell. 34: 922-938.e7. PMID 30537514 DOI: 10.1016/J.Ccell.2018.11.005 |
0.495 |
|
| 2018 |
Ben-David U, Siranosian B, Ha G, Tang H, Oren Y, Hinohara K, Strathdee CA, Dempster J, Lyons NJ, Burns R, Nag A, Kugener G, Cimini B, Tsvetkov P, Maruvka YE, ... ... Bandopadhayay P, et al. Genetic and transcriptional evolution alters cancer cell line drug response. Nature. PMID 30089904 DOI: 10.1038/S41586-018-0409-3 |
0.744 |
|
| 2018 |
Filbin MG, Tirosh I, Hovestadt V, Shaw ML, Escalante LE, Mathewson ND, Neftel C, Frank N, Pelton K, Hebert CM, Haberler C, Yizhak K, Gojo J, Egervari K, Mount C, ... ... Bandopadhayay P, et al. Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq. Science (New York, N.Y.). 360: 331-335. PMID 29674595 DOI: 10.1126/Science.Aao4750 |
0.539 |
|
| 2018 |
Bandopadhayay P, Meyerson M. Landscapes of childhood tumours. Nature. 555: 316-317. PMID 29542703 DOI: 10.1038/d41586-018-01648-4 |
0.325 |
|
| 2018 |
Wala JA, Bandopadhayay P, Greenwald N, O'Rourke R, Sharpe T, Stewart C, Schumacher S, Li Y, Weischenfeldt J, Yao X, Nusbaum C, Campbell P, Getz G, Meyerson M, Zhang CZ, et al. SvABA: genome-wide detection of structural variants and indels by local assembly. Genome Research. PMID 29535149 DOI: 10.1101/Gr.221028.117 |
0.76 |
|
| 2018 |
Dharia NV, Malone C, Iniguez AB, Guenther L, Chen L, Alexe G, Durbin AD, Zimmerman MW, Hong A, Bandopadhayay P, Filbin MG, Howard T, Paolella B, Fung I, Lee J, et al. Abstract 2352: Defining a pediatric cancer dependency map Cancer Research. 78: 2352-2352. DOI: 10.1158/1538-7445.Am2018-2352 |
0.775 |
|
| 2018 |
Pagès M, Rotem D, Gydush G, Reed S, Rhoades J, Ha G, Lo C, Tracy A, Jones R, Becker S, Haller M, Chi S, Kieran M, Goumnerova L, Love C, ... ... Bandopadhayay P, et al. Gene-07. Liquid Biopsy Detection Of Genomic Alterations In Pediatric Brain Tumors From Cell-Free Dna In Peripheral Blood, Csf, And Urine Neuro-Oncology. 20. DOI: 10.1093/Neuonc/Noz036.078 |
0.505 |
|
| 2018 |
Blandin A, Graham M, Ramkissoon S, Ramkissoon L, Pelton K, Pages M, Jones R, Becker S, Watkinson F, Schoolcraft K, Haemels V, Goumnerova L, Chi S, Wright K, Kieran M, ... ... Bandopadhayay P, et al. Pdtm-06. Alk Amplification And Rearrangements Are Recurrent Targetable Events In Glioblastoma Neuro-Oncology. 20. DOI: 10.1093/Neuonc/Noy148.848 |
0.418 |
|
| 2018 |
Touat M, Santagata S, Guillerm E, Bi W, Beuvon F, Mokhtari K, Giry M, Guegan J, Block S, Carpentier A, Delattre J, Sanson M, Duval A, Beroukhim R, Bandopadhayay P, et al. PATH-16. MOLECULAR PATHOLOGY AND CLINICAL CHARACTERISTICS OF MMR DEFICIENCY (MMRd) IN DIFFUSE GLIOMAS Neuro-Oncology. 20: vi161-vi161. DOI: 10.1093/Neuonc/Noy148.672 |
0.59 |
|
| 2018 |
Reitman Z, Paolella B, Bergthold G, Pelton K, Becker S, Jones R, Herbert Z, Grimmett L, Daley J, Filbin M, Suva M, Goumnerova L, Wright K, Chi S, Kieran M, ... ... Bandopadhayay P, et al. LGG-13. RESOLVING TRANSCRIPTIONAL PROFILES IN BRAF-REARRANGED PILOCYTIC ASTROCYTOMA USING SINGLE CELL RNA SEQUENCING Neuro-Oncology. 20: i107-i107. DOI: 10.1093/Neuonc/Noy059.355 |
0.778 |
|
| 2017 |
Greenwald NF, Bandopadhayay P, Beroukhim R. Open data: Spot data glitches before publication. Nature. 550: 333. PMID 29052624 DOI: 10.1038/550333C |
0.364 |
|
| 2017 |
Jones DTW, Kieran MW, Bouffet E, Alexandrescu S, Bandopadhayay P, Bornhorst M, Ellison D, Fangusaro J, Fisher MI, Foreman N, Fouladi M, Hargrave D, Hawkins C, Jabado N, Massimino M, et al. Pediatric Low-Grade Gliomas: Next Biologically Driven Steps. Neuro-Oncology. PMID 29016845 DOI: 10.1093/Neuonc/Nox141 |
0.311 |
|
| 2017 |
D'Aronco L, Rouleau C, Gayden T, Crevier L, Décarie JC, Perreault S, Jabado N, Bandopadhayay P, Ligon KL, Ellezam B. Brainstem angiocentric gliomas with MYB-QKI rearrangements. Acta Neuropathologica. PMID 28803398 DOI: 10.1007/S00401-017-1763-1 |
0.717 |
|
| 2017 |
Paolella BR, Gibson WJ, Urbanski LM, Alberta JA, Zack TI, Bandopadhayay P, Nichols CA, Agarwalla PK, Brown MS, Lamothe R, Yu Y, Choi PS, Obeng EA, Heckl D, Wei G, et al. Copy-number and gene dependency analysis reveals partial copy loss of wild-type SF3B1 as a novel cancer vulnerability. Elife. 6. PMID 28177281 DOI: 10.7554/Elife.23268 |
0.786 |
|
| 2017 |
Ramkissoon SH, Bandopadhayay P, Hwang J, Ramkissoon LA, Greenwald NF, Schumacher SE, O'Rourke R, Pinches N, Ho P, Malkin H, Sinai C, Filbin M, Plant A, Bi WL, Chang MS, et al. Clinical targeted exome-based sequencing in combination with genome-wide copy number profiling: precision medicine analysis of 203 pediatric brain tumors. Neuro-Oncology. PMID 28104717 DOI: 10.1093/Neuonc/Now294 |
0.642 |
|
| 2017 |
Paolella BR, Gibson WJ, Urbanski LM, Alberta JA, Zack TI, Bandopadhayay P, Nichols CA, Agarwalla PK, Brown MS, Lamothe R, Yu Y, Choi PS, Obeng EA, Heckl D, Wei G, et al. Author response: Copy-number and gene dependency analysis reveals partial copy loss of wild-type SF3B1 as a novel cancer vulnerability Elife. DOI: 10.7554/Elife.23268.025 |
0.781 |
|
| 2017 |
Bandopadhayay P, Paolella B, O’Rourke R, Ho P, Greenwald N, Sharpira O, Pantel S, Bagul M, Tracy A, Roti G, Balboni A, Vazquez F, Ligon K, Piccioni F, Stegmaier K, et al. TRTH-15. RESISTANCE MECHANISMS TO BET-BROMODOMAIN INHIBITION IN MYC-AMPLIFIED MEDULLOBLASTOMA Neuro-Oncology. 19: iv54-iv55. DOI: 10.1093/Neuonc/Nox083.227 |
0.704 |
|
| 2017 |
Rouleau C, Bandopadhayay P, Ramkissoon L, Beroukhim R. Lgg-06. Functional And Therapeutic Relevance Of Myb-Qki-Induced Transcriptional Events To Gliomagenesis. Neuro-Oncology. 19. DOI: 10.1093/Neuonc/Nox083.139 |
0.417 |
|
| 2017 |
Paolella B, Bandopadhayay P, Bergthold G, Shalek A, Pelton K, Ramkissoon S, Sinai C, Malkin H, Herbert Z, Sun Y, Alberta J, Brown M, Daley J, Lazo-Kallanian S, Goumnerova L, et al. LGG-05. SINGLE-CELL RNA SEQUENCING OF PEDIATRIC LOW-GRADE GLIOMAS REVEALS INTRATUMORAL HETEROGENEITY Neuro-Oncology. 19: iv33-iv34. DOI: 10.1093/Neuonc/Nox083.138 |
0.788 |
|
| 2017 |
Bandopadhayay P, Ramkissoon S, Hwang J, Ramkissoon L, Greenwald N, Schumacher S, O’Rourke R, Pinches N, Ho P, Malkin H, Sinai C, Filbin M, Plant A, Bi W, Chang M, et al. GENE-09. PRECISION MEDICINE ANALYSIS OF 203 PEDIATRIC BRAIN TUMORS REVEALS CLINICALLY RELEVANT GENOMIC ALTERATIONS Neuro-Oncology. 19: iv20-iv20. DOI: 10.1093/Neuonc/Nox083.080 |
0.661 |
|
| 2017 |
Bandopadhayay P, Greenwald NF, Wala J, Sharpira O, Tracy A, Filbin M, O’Rourke R, Ho P, Sinai C, Malkin H, Greenspan L, Lawler K, Pelton K, Banerjee A, Becher O, et al. DIPG-29. GENOMIC LANDSCAPE OF DIFFUSE INTRINSIC PONTINE GLIOMA: AN ANALYSIS OF THE DIPG-BATS COHORT Neuro-Oncology. 19: iv11-iv11. DOI: 10.1093/Neuonc/Nox083.044 |
0.723 |
|
| 2017 |
Paolella B, Gibson W, Urbanski L, Alberta J, Zack T, Bandopadhayay P, Nichols C, Brown M, Lamothe R, Yu Y, Choi P, Obeng E, Wei G, Wong B, Tsherniak A, et al. BIOL-04. INTEGRATED COPY-NUMBER AND CANCER DEPENDENCY ANALYSIS REVEALS ALTERED SPLICEOSOME STOICHIOMETRY AS A NOVEL VULNERABILITY IN GENOMICALLY DISRUPTED CANCERS Neuro-Oncology. 19: iv4-iv4. DOI: 10.1093/Neuonc/Nox083.012 |
0.786 |
|
| 2016 |
Ni J, Xie S, Ramkissoon SH, Luu V, Sun Y, Bandopadhayay P, Beroukhim R, Roberts TM, Stiles CD, Segal RA, Ligon KL, Hahn WC, Zhao JJ. Tyrosine receptor kinase B is a drug target in astrocytomas. Neuro-Oncology. PMID 27402815 DOI: 10.1093/Neuonc/Now139 |
0.454 |
|
| 2016 |
Dodgshun AJ, SantaCruz N, Hwang J, Ramkissoon SH, Malkin H, Bergthold G, Manley P, Chi S, MacGregor D, Goumnerova L, Sullivan M, Ligon K, Beroukhim R, Herrington B, Kieran MW, ... ... Bandopadhayay P, et al. Disseminated glioneuronal tumors occurring in childhood: treatment outcomes and BRAF alterations including V600E mutation. Journal of Neuro-Oncology. PMID 26994902 DOI: 10.1007/S11060-016-2109-X |
0.777 |
|
| 2016 |
Bandopadhayay P, Ramkissoon LA, Jain P, Bergthold G, Wala J, Zeid R, Schumacher SE, Urbanski L, O'Rourke R, Gibson WJ, Pelton K, Ramkissoon SH, Han HJ, Zhu Y, Choudhari N, et al. MYB-QKI rearrangements in angiocentric glioma drive tumorigenicity through a tripartite mechanism. Nature Genetics. PMID 26829751 DOI: 10.1038/Ng.3500 |
0.805 |
|
| 2016 |
Ramkissoon L, Bandopadhayay P, Jain P, Bergthold G, Resnick A, Beroukhim R, Ligon K. Abstract 4372: MYB-QKI rearrangements in angiocentric glioma drive tumorigenicity through a tripartite mechanism Cancer Research. 76: 4372-4372. DOI: 10.1158/1538-7445.Am2016-4372 |
0.803 |
|
| 2016 |
Paolella BR, Gibson WJ, Urbanski LM, Alberta JA, Zack TI, Bandopadhayay P, Nichols CA, Agarwalla PK, Brown MS, Lamothe R, Yu Y, Choi PS, Obeng EA, Heckl D, Ebert BL, et al. Abstract 4369: Genome-wide copy number dependency analysis identifies partial copy loss of SF3B1 as a novel cancer vulnerability Cancer Research. 76: 4369-4369. DOI: 10.1158/1538-7445.Am2016-4369 |
0.789 |
|
| 2016 |
Kieran MW, Sun Y, Pilarz C, Calligaris D, Chadwick EJ, Alberta JA, Ramkissoon SH, Ramkissoon LA, Garcia VM, Wilkinson K, Kane M, Goumnerova L, Chi SN, Manley P, Wright KD, ... ... Bandopadhayay P, et al. LG-47TYPE II RAF INHIBITORS INHIBIT BRAF MUTATIONS AND TRUNCATED FUSIONS IN PEDIATRIC LOW-GRADE GLIOMAS Neuro-Oncology. 18: iii89.2-iii89. DOI: 10.1093/Neuonc/Now075.47 |
0.51 |
|
| 2016 |
Bergthold G, Bandopadhayay P, Ramkissoon L, Jain P, Wala J, Schumacher S, Ramkissoon S, Varlet P, Pages M, Ducar M, Van Hummelen P, Bowers D, Giannini C, Puget S, Hawkins C, et al. LG-02MYB-QKI REARRANGEMENTS IN ANGIOCENTRIC GLIOMA DRIVE TUMORIGENICITY THROUGH A TRIPARTITE MECHANISM Neuro-Oncology. 18: iii78.2-iii78. DOI: 10.1093/Neuonc/Now075.02 |
0.778 |
|
| 2016 |
Wright KD, Bandopadhayay P, Gourmnerova L, Chi SN, Manley P, Marcus K, Kannan G, Banerjee A, Becher O, Bendel A, Bowers D, Bredlau A, Cohen K, Comito M, Elster JD, et al. HG-73SAFETY AND FEASIBILITY OF A MULTI-INSTITUTIONAL PHASE II TRIAL INCOPORATING BIOPSY AND MOLECULARLY DETERMINED TREATMENT OF CHILDREN AND YOUNG ADULTS WITH NEWLY DIAGNOSED DIFFUSE INTRINSIC PONTINE GLIOMAS (DIPG) Neuro-Oncology. 18: iii65.1-iii65. DOI: 10.1093/Neuonc/Now073.69 |
0.415 |
|
| 2016 |
Bandopadhayay P, Ramkissoon S, Hwang J, Ramkissoon L, Dubuc A, Schumacher S, Janeway K, Pinches N, Malkin H, Sinai C, Manley P, Wright K, Filbin M, Goumnerova L, Alexandrescu S, et al. Ept-20Clinical Targeted Exome-Based Sequencing In Combination With Genome Wide Copy Number Profiling: A Clia Certified Approach For Precision Medicine In 203 Pediatric Brain Tumor Patients Neuro-Oncology. 18. DOI: 10.1093/Neuonc/Now069.19 |
0.524 |
|
| 2015 |
Bandopadhayay P, Silvera VM, Ciarlini PD, Malkin H, Bi WL, Bergthold G, Faisal AM, Ullrich NJ, Marcus K, Scott RM, Beroukhim R, Manley PE, Chi SN, Ligon KL, Goumnerova LC, et al. Myxopapillary ependymomas in children: imaging, treatment and outcomes. Journal of Neuro-Oncology. PMID 26468139 DOI: 10.1007/S11060-015-1955-2 |
0.774 |
|
| 2015 |
Bergthold G, Bandopadhayay P, Hoshida Y, Ramkissoon S, Ramkissoon L, Rich B, Maire CL, Paolella BR, Schumacher SE, Tabak B, Ferrer-Luna R, Ozek M, Sav A, Santagata S, Wen PY, et al. Expression profiles of 151 pediatric low-grade gliomas reveal molecular differences associated with location and histological subtype. Neuro-Oncology. PMID 25825052 DOI: 10.1093/Neuonc/Nov045 |
0.814 |
|
| 2015 |
Baratta MG, Schinzel AC, Zwang Y, Bandopadhayay P, Bowman-Colin C, Kutt J, Curtis J, Piao H, Wong LC, Kung AL, Beroukhim R, Bradner JE, Drapkin R, Hahn WC, Liu JF, et al. An in-tumor genetic screen reveals that the BET bromodomain protein, BRD4, is a potential therapeutic target in ovarian carcinoma. Proceedings of the National Academy of Sciences of the United States of America. 112: 232-7. PMID 25535366 DOI: 10.1073/Pnas.1422165112 |
0.521 |
|
| 2014 |
Tang Y, Gholamin S, Schubert S, Willardson MI, Lee A, Bandopadhayay P, Bergthold G, Masoud S, Nguyen B, Vue N, Balansay B, Yu F, Oh S, Woo P, Chen S, et al. Epigenetic targeting of Hedgehog pathway transcriptional output through BET bromodomain inhibition. Nature Medicine. 20: 732-40. PMID 24973920 DOI: 10.1038/Nm.3613 |
0.521 |
|
| 2014 |
Bergthold G, Bandopadhayay P, Bi WL, Ramkissoon L, Stiles C, Segal RA, Beroukhim R, Ligon KL, Grill J, Kieran MW. Pediatric low-grade gliomas: how modern biology reshapes the clinical field. Biochimica Et Biophysica Acta. 1845: 294-307. PMID 24589977 DOI: 10.1016/J.Bbcan.2014.02.004 |
0.808 |
|
| 2014 |
Bandopadhayay P, Bergthold G, London WB, Goumnerova LC, Morales La Madrid A, Marcus KJ, Guo D, Ullrich NJ, Robison NJ, Chi SN, Beroukhim R, Kieran MW, Manley PE. Long-term outcome of 4,040 children diagnosed with pediatric low-grade gliomas: an analysis of the Surveillance Epidemiology and End Results (SEER) database. Pediatric Blood & Cancer. 61: 1173-9. PMID 24482038 DOI: 10.1002/Pbc.24958 |
0.747 |
|
| 2014 |
Bandopadhayay P, Bergthold G, Nguyen B, Schubert S, Gholamin S, Tang Y, Bolin S, Schumacher SE, Zeid R, Masoud S, Yu F, Vue N, Gibson WJ, Paolella BR, Mitra SS, et al. BET bromodomain inhibition of MYC-amplified medulloblastoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 912-25. PMID 24297863 DOI: 10.1158/1078-0432.Ccr-13-2281 |
0.792 |
|
| 2014 |
Bandopadhayay P, Chi S, Janeway K, Pinches N, Malkin H, Manley P, Goumnerova L, Chang M, Kieran M, Harris M, Ramkissoon S, Ligon K. Ge-02Clinical Targeted Exome-Based Sequencing For Children Diagnosed With Brain Tumors: Initial Results Of An Institute-Wide Project On Personalized Medicine Neuro-Oncology. 16. DOI: 10.1093/Neuonc/Nou256.2 |
0.355 |
|
| 2014 |
Cho Y, Tang Y, Schubert S, Willardson M, Bandopadhayay P, Bergthold G, Nguyen B, Masoud S, Vue N, Balansay B, Gholamin S, Cheshier SH, Atwood SX, Whitson RJ, Lee A, et al. EPIGENETIC TARGETING OF HEDGEHOG PATHWAY TRANSCRIPTIONAL OUTPUT Neuro-Oncology. 16: iii25-iii25. DOI: 10.1093/Neuonc/Nou208.9 |
0.559 |
|
| Show low-probability matches. |